Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Dusseldorf - Delayed Quote EUR

Akeso Inc (4RY.DU)

Compare
8.70
-0.05
(-0.57%)
As of 12:30:21 PM GMT+1. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,526,253
4,526,253
837,656
225,626
--
Cost of Revenue
133,248
133,248
94,117
31,259
--
Gross Profit
4,393,005
4,393,005
743,539
194,367
--
Operating Expense
2,226,181
2,226,181
1,965,561
1,460,801
952,423
Operating Income
2,166,824
2,166,824
-1,222,022
-1,266,434
-952,423
Net Non Operating Interest Income Expense
32,746
32,746
-21,318
3,884
26,518
Pretax Income
1,942,525
1,942,525
-1,422,216
-1,258,126
-1,320,579
Tax Provision
174
174
--
--
--
Net Income Common Stockholders
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,036,374
Diluted NI Available to Com Stockholders
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,036,374
Basic EPS
2.42
--
-1.42
-1.32
-1.65
Diluted EPS
2.42
--
-1.42
-1.32
-1.65
Basic Average Shares
837,683.78
--
824,989.86
815,931.80
628,941.61
Diluted Average Shares
837,821.48
--
824,989.86
815,931.80
628,941.61
Rent Expense Supplemental
2,683
--
--
--
--
Total Expenses
2,359,429
2,359,429
2,059,678
1,492,060
952,423
Net Income from Continuing & Discontinued Operation
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,177,051
Normalized Income
1,976,198.67
1,976,198.67
-1,174,497
-1,083,455
-1,184,074
Interest Income
119,733
119,733
21,972
14,236
34,505
Interest Expense
86,987
86,987
43,290
10,352
7,987
Net Interest Income
32,746
32,746
-21,318
3,884
26,518
EBIT
2,029,512
2,029,512
-1,378,926
-1,247,774
-1,312,592
EBITDA
2,172,280
2,172,280
-1,273,137
-1,189,531
-1,290,485
Reconciled Cost of Revenue
133,248
133,248
94,117
31,259
--
Reconciled Depreciation
142,768
142,768
105,789
58,243
22,107
Net Income from Continuing Operation Net Minority Interest
2,028,300
2,028,300
-1,168,393
-1,074,933
-1,177,051
Total Unusual Items Excluding Goodwill
52,106
52,106
6,104
8,522
7,023
Total Unusual Items
52,106
52,106
6,104
8,522
7,023
Normalized EBITDA
2,120,174
2,120,174
-1,279,241
-1,198,053
-1,297,508
Tax Rate for Calcs
0
0
--
--
--
Tax Effect of Unusual Items
4.67
4.67
--
--
--
12/31/2020 - 4/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AGTX Agentix Corp.
0.0820
0.00%
 
G28.F Tevogen Bio Holdings Inc.
1.1700
0.00%
 
IVBIY Innovent Biologics Inc.
19.15
0.00%
 
TVGNW Tevogen Bio Holdings Inc.
0.0668
+11.33%
 
PCSA Processa Pharmaceuticals, Inc.
0.5490
+3.58%
 
GLPG.AS Galapagos NV
25.40
+1.68%
 
JUNS Jupiter Neurosciences, Inc.
0.6510
-2.69%
 
IGMS IGM Biosciences, Inc.
1.3600
+1.49%
 
HCWB HCW Biologics Inc.
0.3802
+0.32%
 
OSTX OS Therapies Incorporated
1.6500
+0.61%